These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33117448)

  • 21. Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity.
    Mohamed RZ; Jalaludin MY; Anuar Zaini A
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):247-253. PubMed ID: 31926095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence, Metabolic Profile, and Associated Risk Factors of Non-alcoholic Fatty Liver Disease in an Adult Population of India.
    Singhai A; Yadav V; Joshi R; Malik R; T SB; Kamle S
    Cureus; 2023 Jan; 15(1):e33977. PubMed ID: 36820120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population.
    Lin IT; Lee MY; Wang CW; Wu DW; Chen SC
    Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33498329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of Anthropometric Obesity and Computed Tomography Measured Nonalcoholic Fatty Liver Disease (from the Multiethnic Study of Atherosclerosis).
    Tison GH; Blaha MJ; Nasir K; Blumenthal RS; Szklo M; Ding J; Budoff MJ
    Am J Cardiol; 2015 Aug; 116(4):541-6. PubMed ID: 26070222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of anthropometric indices for the screening of nonalcoholic fatty liver disease in pre- and postmenopausal women.
    Hong SH; Hwang SY; Kim JA; Lee YB; Roh E; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
    Menopause; 2020 Jan; 27(1):88-94. PubMed ID: 31613826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impacts of types and degree of obesity on non-alcoholic fatty liver disease and related dyslipidemia in Chinese school-age children?
    Meng L; Luo N; Mi J
    Biomed Environ Sci; 2011 Feb; 24(1):22-30. PubMed ID: 21440836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determining the best method for evaluating obesity and the risk for non-communicable diseases in women of childbearing age by measuring the body mass index, waist circumference, waist-to-hip ratio, waist-to-height ratio, A Body Shape Index, and hip index.
    Hewage N; Wijesekara U; Perera R
    Nutrition; 2023 Oct; 114():112135. PubMed ID: 37453224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Waist-to-height ratio is independently related to whole and central body fat, regardless of the waist circumference measurement protocol, in non-alcoholic fatty liver disease patients.
    Pimenta NM; Cortez-Pinto H; Melo X; Silva-Nunes J; Sardinha LB; Santa-Clara H
    J Hum Nutr Diet; 2017 Apr; 30(2):185-192. PubMed ID: 27600326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease.
    Zeng J; Yang RX; Sun C; Pan Q; Zhang RN; Chen GY; Hu Y; Fan JG
    World J Gastroenterol; 2020 Apr; 26(15):1792-1804. PubMed ID: 32351294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes.
    Altalebi RR; Al-Hussaniy HA; Al-Tameemi ZS; Al-Zobaidy MA; Albu-Rghaif AH; Alkuraishy HM; Hedeab GM; Azam F; Al-Samydai AM; Naji MA
    J Med Life; 2023 Jan; 16(1):42-47. PubMed ID: 36873135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional anthropometric measures associated with the severity of liver injury in patients with non-alcoholic fatty liver disease.
    Subramanian V; Johnston RD; Kaye P; Aithal GP
    Aliment Pharmacol Ther; 2013 Feb; 37(4):455-63. PubMed ID: 23293873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.
    Khamseh ME; Malek M; Abbasi R; Taheri H; Lahouti M; Alaei-Shahmiri F
    Metab Syndr Relat Disord; 2021 Apr; 19(3):167-173. PubMed ID: 33259744
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of Abdominal Fat Distribution in Non-Alcoholic Fatty Liver Disease by Magnetic Resonance Imaging: a Population-based Study.
    Radmard AR; Rahmanian MS; Abrishami A; Yoonessi A; Kooraki S; Dadgostar M; Hashemi Taheri AP; Gerami Seresht M; Poustchi H; Jafari E; Malekzadeh R; Merat S
    Arch Iran Med; 2016 Oct; 19(10):693-699. PubMed ID: 27743433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai].
    Wan YP; Xu RY; Fang H; Lu LP; Zhang XM; Cai W
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):644-8. PubMed ID: 17903363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
    Tan EX; Lee JW; Jumat NH; Chan WK; Treeprasertsuk S; Goh GB; Fan JG; Song MJ; Charatcharoenwitthaya P; Duseja A; Imajo K; Nakajima A; Seki Y; Kasama K; Kakizaki S; Lesmana LA; Zheng KI; Zheng MH; Koh CJ; Ho KY; Goh KL; Wong VW; Dan YY
    Metabolism; 2022 Jan; 126():154911. PubMed ID: 34648769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease.
    Kuang M; Sheng G; Hu C; Lu S; Peng N; Zou Y
    Lipids Health Dis; 2022 Oct; 21(1):104. PubMed ID: 36266655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of neck circumference-related indices with metabolic, atherogenic and liver function biomarkers in patients with non-alcoholic fatty liver disease: a cross-sectional study.
    Arefhosseini S; Tutunchi H; Tavakkoli S; Arefhosseini SR; Ebrahimi-Mameghani M
    BMJ Open; 2023 Sep; 13(9):e073452. PubMed ID: 37699622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.